Grünenthal

@grunenthalgroup

Grünenthal is a global leader in pain management and related diseases. / Profile maintained by Global Communications

Vrijeme pridruživanja: rujan 2016.

Tweetovi

Blokirali ste korisnika/cu @grunenthalgroup

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @grunenthalgroup

  1. Prikvačeni tweet
    30. tra 2019.

    2018 was a decisive year for Grünenthal – both strategically and financially. We have advanced our pipeline, while further executing our strategy at high pace. Read more in the Grünenthal Report 2018/19:

    Poništi
  2. 7. stu 2019.

    We want to re-define the field of , creating targeted treatments through patient-inspired R&D. Collaboration is central to our strategy - bringing together patient experience, payors’ needs and innovation networks.

    Poništi
  3. 5. stu 2019.

    The 10-year anniversary Symposium “Bringing pain policy to the next decade” is fast approaching. SIP is an international platform created in 2009 as a joint initiative of the and . Join the live stream on November 7th:

    Poništi
  4. 11. lis 2019.

    Current achievements, challenges and misconceptions about . On the occasion of , we talked to Professor Roman Rolke, Director of the Clinic for Palliative Medicine at Aachen. Read more

    Poništi
  5. 24. ruj 2019.

    Grünenthal was paired up with Franziska Wetzl (), who runs a blog and Instagram account about her everyday life with fibromyalgia, about chronic disease and invisible handicaps. Join the livestream on September 26! [only available in German]

    Poništi
  6. 9. ruj 2019.

    We are teaming up with to develop a Phase III cell therapy candidate for the treatment of chronic low back pain due to degenerative disc disease. The aim is to deliver meaningful lasting improvements to patients.

    Poništi
  7. 2. ruj 2019.

    Tomorrow is the start of ! is excited to meet with HCPs, researchers and other members of the pain community to discuss how we can improve the lives of patients with chronic pain. Come and see us at Booth 17

    Poništi
  8. 30. kol 2019.

    Join us at to consider the future of pain management, and what we can do to improve the lives of patients through . Paul Ratcliffe our Head of Research explains more about our vision for a here:

    Poništi
  9. 27. kol 2019.

    With around the corner, the 11th Congress of the European Pain Federation (®), taking place 4 – 7 September in Valencia, Spain, we reflect on the personal impact of living with . Hear Barby Ingle’s story here

    Poništi
  10. 23. kol 2019.

    This month for our ‘Paper of the Month’ feature, we have chosen “Transition from acute to chronic pain after surgery” by Glare P et al. Click here to view our summary:

    Poništi
  11. 15. kol 2019.

    Central sensitisation pathways have been demonstrated in a diverse group of conditions. One commonality between them is their negative impact on quality of life. Read more in our article here:

    Poništi
  12. 9. kol 2019.

    Are you interested to learn more about the , how it was developed and the reasoning behind it? Read our PainSpectrum introductory article on the website here.

    Poništi
  13. 26. srp 2019.

    Thanks to everyone who attended the third webinar in our series which focused on placebo in . If you are a member of the community, click here to view a recording of the webinar and read a summary article:

    Poništi
  14. 18. srp 2019.

    PainSolve contains an extensive library of our pain publications, developed over several years alongside pain experts which aim to enhance understanding of pain diseases. You can view the library & request access to papers here:

    Poništi
  15. 11. srp 2019.

    The represents 8 years of work, bringing together input from pain experts around the world into condition-specific modules. The latest 20 modules are now available on the site. Explore the full library:

    Poništi
  16. 11. srp 2019.

    Proud to support the Brain, Mind, and Pain Patient-Centred Innovation Grant !

    Poništi
  17. 5. srp 2019.

    The unique aspect of a patient focus group is the interaction among patients as well as between the moderator and the group. In this article, we introduce patient focus group methodology and its role in .

    Poništi
  18. 28. lip 2019.

    In order to improve disease understanding and explore the underlying pathophysiologies of pain, we have used the omics approach to create an integrated map. Click here to view the overlapping pathways of 8 different pain indications:

    Poništi
  19. 21. lip 2019.

    This month for our ‘Paper of the Month’ feature, we have chosen “Psychological and work-related outcomes after inpatient multidisciplinary rehabilitation of chronic low back pain: a prospective randomised controlled trial” by Hampel P et al.

    Poništi
  20. 14. lip 2019.

    The fourth webinar on the many challenges of small fibre neuropathy () recently took place–thank you to everyone who attended. For anyone who was unable to join, please click here to view a recording of the webinar and read a summary article:

    Poništi
  21. 12. lip 2019.

    Patient voice in gout: A pan-European survey initiated by Grünenthal and presented at the Annual European Congress of Rheumatology indicates that gout is being diagnosed late, is not well controlled, and not monitored regularly:

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·